Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Ocugen (OCGN) Net Income towards Common Stockholders (2016 - 2025)

Historic Net Income towards Common Stockholders for Ocugen (OCGN) over the last 12 years, with Q3 2025 value amounting to -$20.1 million.

  • Ocugen's Net Income towards Common Stockholders fell 5459.52% to -$20.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$64.0 million, marking a year-over-year decrease of 2523.13%. This contributed to the annual value of -$54.0 million for FY2024, which is 1437.59% up from last year.
  • Per Ocugen's latest filing, its Net Income towards Common Stockholders stood at -$20.1 million for Q3 2025, which was down 5459.52% from -$14.7 million recorded in Q2 2025.
  • Ocugen's 5-year Net Income towards Common Stockholders high stood at -$7.1 million for Q1 2021, and its period low was -$26.0 million during Q2 2021.
  • Its 5-year average for Net Income towards Common Stockholders is -$16.4 million, with a median of -$15.3 million in 2024.
  • Its Net Income towards Common Stockholders has fluctuated over the past 5 years, first crashed by 28472.3% in 2021, then surged by 4999.77% in 2023.
  • Ocugen's Net Income towards Common Stockholders (Quarter) stood at -$14.6 million in 2021, then crashed by 50.46% to -$21.9 million in 2022, then soared by 50.0% to -$11.0 million in 2023, then decreased by 26.55% to -$13.9 million in 2024, then crashed by 44.44% to -$20.1 million in 2025.
  • Its Net Income towards Common Stockholders stands at -$20.1 million for Q3 2025, versus -$14.7 million for Q2 2025 and -$15.4 million for Q1 2025.